Clinical Trial Update: Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of levetiracetam on memory function in amnestic mild cognitive impairment, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: Johns Hopkins University | Conditions: Mild Cognitive Impairment (MCI) | Phase 2 | Status: COMPLETED | Results posted: 2017-08-21